Thymolin
ExperimentalThymic peptide / researchExperimental
Vendor thymic-immune peptide listing; identity may overlap thymulin/thymogen/thymalin depending on supplier. Not FDA-approved.
For research use only.
Key Facts
- CAS
- —
- Molecular Weight (MW)
- —
- Half-life
- Not established
- Unit
- mg
- Administration Route
- Subcutaneous
- Frequency
- —
- Last updated
- 8/23/2026
- Targets
- Thymic immune signaling (claimed)
Overview
Vendor thymic-immune peptide listing; identity may overlap thymulin/thymogen/thymalin depending on supplier. Not FDA-approved.
Protocol
- Dosage Range
- —
- Frequency
- —
- Cycle
- —
- Administration Route
- Subcutaneous
- Reconstitution Guide
- —
Science
Mechanism of Action
Marketed as a thymic immunomodulator. Confirm the actual sequence on a COA — the name is not a single INN.
Targets
Thymic immune signaling (claimed)
Studies
- Thymic peptides review— Journal/year not available
Benefits
Immune-catalog item
Potential Side Effects
- Unknown / product-dependent
References
- PMID 10853205External link · Year —